Sushant Singh Rajput's death has been one of the biggest tragedies ever in Bollywood. At 34, the talented actor was gone too soon. The death has left fans in mourning for more than two months now. Yesterday, a new and explosive angle has come up in the investigations. Times Now has accessed some chats of Rhea Chakraborty where she is allegedly talking about drugs. We can read mentions of MDMA (Ecstasy), hash and marijuana in the chats. In one of the chats between Jaya Saha and Rhea Chakraborty, it is written, "Use 4 drops in tea, let him sip it." These chats have taken place in 2017, 2019-2020.
Vikas Singh, who is representing the family of Sushant Singh Rajput told Times Now that this was an explosive revelation. He said that the family in its FIR had alleged that she had overdosed him with anti-psychotic drugs. He spoke about how servants mentioned that her family and friends would be partying downstairs as Sushant Singh Rajput slept on the top floor of the duplex apartment. The family lawyer said that if these allegations are true then perhaps she used them to make him docile and control his mind. They have said in their FIR that nor Sushant or any of the family members have any history of mental illness.
Meanwhile, people are shocked on Twitter after this expose. #RheaDrugChat is trending all over India. The actor's servant Neeraj has spoken about how Sushant Singh Rajput would allegedly consume marijuana cigarettes and Samuel Miranda would roll the same. He said parties would happen twice a week. On the medical side, he was given administered Quetiapine, a strong anti-psychotic drug. Siddharth Pithani remembered the name of the medicine after many interviews. Quetiapine is used in treatment of bipolar disorder, schizophrenia and manic depression. The whole case is getting murkier by the day.
Stay tuned to BollywoodLife for the latest scoops and updates from Bollywood, Hollywood, South, TV and Web-Series.
Click to join us on Facebook, Twitter, Youtube and Instagram. Also follow us on Facebook Messenger for latest updates.